[go: up one dir, main page]

DK1066029T3 - Suspension af peroralt aktivt middel - Google Patents

Suspension af peroralt aktivt middel

Info

Publication number
DK1066029T3
DK1066029T3 DK99913291T DK99913291T DK1066029T3 DK 1066029 T3 DK1066029 T3 DK 1066029T3 DK 99913291 T DK99913291 T DK 99913291T DK 99913291 T DK99913291 T DK 99913291T DK 1066029 T3 DK1066029 T3 DK 1066029T3
Authority
DK
Denmark
Prior art keywords
suspension
active agent
orally active
orally
agent
Prior art date
Application number
DK99913291T
Other languages
English (en)
Inventor
Dietrich Tuerck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1066029T3 publication Critical patent/DK1066029T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99913291T 1998-03-27 1999-03-23 Suspension af peroralt aktivt middel DK1066029T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (de) 1998-03-27 1998-03-27 Perorale Wirkstoff-Suspension
PCT/EP1999/001948 WO1999049845A1 (de) 1998-03-27 1999-03-23 Perorale wirkstoff-suspension

Publications (1)

Publication Number Publication Date
DK1066029T3 true DK1066029T3 (da) 2003-01-27

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913291T DK1066029T3 (da) 1998-03-27 1999-03-23 Suspension af peroralt aktivt middel

Country Status (25)

Country Link
EP (2) EP0945131A1 (da)
JP (1) JP3323189B2 (da)
KR (1) KR100587208B1 (da)
CN (1) CN1150888C (da)
AR (1) AR016196A1 (da)
AT (1) ATE225648T1 (da)
AU (1) AU762464B2 (da)
BR (1) BR9909189A (da)
CA (1) CA2326048C (da)
CO (1) CO5070601A1 (da)
DE (1) DE59903023D1 (da)
DK (1) DK1066029T3 (da)
ES (1) ES2184428T3 (da)
HU (1) HU228474B1 (da)
IL (1) IL137479A (da)
MY (1) MY124599A (da)
NO (1) NO321401B1 (da)
NZ (1) NZ507610A (da)
PL (1) PL192969B1 (da)
PT (1) PT1066029E (da)
TR (1) TR200002772T2 (da)
TW (1) TWI232759B (da)
UY (1) UY25443A1 (da)
WO (1) WO1999049845A1 (da)
ZA (1) ZA200003951B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
GB2416123B (en) * 2003-04-07 2007-06-06 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
AU2005313365A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
GB2438287A (en) 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
IN2012DN03157A (da) * 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
CA2800235C (en) * 2010-03-10 2018-10-16 Lupin Limited Rifaximin ready-to-use suspension
SG10201706265PA (en) * 2010-03-19 2017-08-30 Boston Biomedical Inc Novel compounds and compositions for targeting cancer stem cells
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
WO2014097685A1 (ja) * 2012-12-19 2014-06-26 三菱電機株式会社 空気調和機
JP2018519794A (ja) 2015-04-28 2018-07-26 マース インコーポレーテッドMars Incorporated 殺菌されたウェットタイプのペットフード製品を調製する方法
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
CN112044605B (zh) * 2019-06-06 2022-06-21 钟志勇 选钛药剂及选钛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
JP2002509875A (ja) 2002-04-02
JP3323189B2 (ja) 2002-09-09
EP1066029A1 (de) 2001-01-10
NZ507610A (en) 2003-08-29
CN1150888C (zh) 2004-05-26
PL192969B1 (pl) 2006-12-29
CN1295462A (zh) 2001-05-16
CA2326048A1 (en) 1999-10-07
HU228474B1 (en) 2013-03-28
HUP0102036A3 (en) 2002-12-28
NO321401B1 (no) 2006-05-08
NO20004822D0 (no) 2000-09-26
IL137479A0 (en) 2001-07-24
PT1066029E (pt) 2003-02-28
AR016196A1 (es) 2001-06-20
ES2184428T3 (es) 2003-04-01
TR200002772T2 (tr) 2000-12-21
PL342345A1 (en) 2001-06-04
BR9909189A (pt) 2000-12-05
TWI232759B (en) 2005-05-21
EP0945131A1 (de) 1999-09-29
HUP0102036A2 (hu) 2002-03-28
ATE225648T1 (de) 2002-10-15
IL137479A (en) 2005-09-25
MY124599A (en) 2006-06-30
DE59903023D1 (en) 2002-11-14
NO20004822L (no) 2000-11-23
CO5070601A1 (es) 2001-08-28
UY25443A1 (es) 1999-11-17
ZA200003951B (en) 2002-01-18
KR100587208B1 (ko) 2006-06-08
AU762464B2 (en) 2003-06-26
WO1999049845A1 (de) 1999-10-07
AU3147099A (en) 1999-10-18
HK1034184A1 (en) 2001-10-19
EP1066029B1 (de) 2002-10-09
KR20010042197A (ko) 2001-05-25
CA2326048C (en) 2008-08-12

Similar Documents

Publication Publication Date Title
DK1066029T3 (da) Suspension af peroralt aktivt middel
ID27092A (id) Pembuatan ftalat anhidrida
IS2325B (is) Örgerðar samsetningar epleróns
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
ATE309998T1 (de) Pharmazeutisch wirksamer sulfonamid derivaten
DE69908638D1 (de) Lithographische kontaktstrukturen
PT1175408E (pt) Derivados sulfonamida
DK199801716A (da) Hovedsæt
EE04240B1 (et) (S)-omeprasooli kaaliumisool
NO20004949D0 (no) Sulfonamidderivater
NO20020222L (no) Oralt aktive androgener
ID28208A (id) Konstruksi penegang pengapung
IS5772A (is) Þalazín (phthalazine) afleiður af fosfódíesterasa4 lötum
DE69911152D1 (de) Symmetrischer Verstärker
ID24677A (id) Kombinasi senyawa aktif fungisidal
DK1155050T3 (da) Fremstilling af polyolefin
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE69907845D1 (de) Sulfonamid-Derivate
NO20013810L (no) Anvendelse av kolesterol senkende middel
ID28397A (id) Struktur alat penstabil
DK1102747T3 (da) Krystalformer af osenetant
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
EE200100381A (et) Morfolinobensamiidi uued soolad
DE69818311D1 (de) Festkörperüberstromrelais